Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care.

Front Neurol · 2021 · PMC8284317 · PMID 34276544

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

A 12-month double-blind trial of the non-liposomal formulation of Coenzyme Q-10 at a dosage of 2,400 mg per day produced a favorable trend, but the high dropout rate reduced the power of the study and the result was non-significant ( p = 0.07) ( 18 ).

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.